histamine h3 antagonists

Preferred Label : histamine h3 antagonists;

MeSH definition : Drugs that selectively bind to but do not activate HISTAMINE H3 RECEPTORS. They have been used to correct SLEEP WAKE DISORDERS and MEMORY DISORDERS.;

MeSH synonym : antihistaminics, h3; h3 antagonists, histamine; h3 blockers, histamine; antagonists, histamine h3; histamine h3 blockers; blockers, histamine h3; histamine h3 receptor antagonists; h3 antihistaminics;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D054828;

UMLS CUI

C1956071;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Histamine H3 receptor antagonist (disposition) [SNOMED CT concept]
- Substance with histamine H3 receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Indexing information
- (4-cyclobutyl-(1,4)diazepan-1-yl)-(6-(4-fluorophenoxy)pyridin-3-yl)methanone [MeSH Supplementary Concept]
- 3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)-N-(2-methylpropyl)cyclobutanecarboxamide [MeSH Supplementary Concept]
- 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol [MeSH Supplementary Concept]
- 5-fluoro-2-methyl-N-(2-methyl-4-(2-methyl(1,3')bipyrrolidinyl-1'-yl)phenyl)benzamide [MeSH Supplementary Concept]
- BP1.4160 [MeSH Supplementary Concept]
- GSK 835726 [MeSH Supplementary Concept]
- N,N-dimethyl-4-(1-oxo-2-(2-pyrrolidin-1-ylethyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)benzamide [MeSH Supplementary Concept]
- N-(4-nitrobenzyl)-N-(4-(7-phenoxyheptylpiperazin-1-yl)butyl)guanidine [MeSH Supplementary Concept]
- N-(4-trifluoromethylbenzyl)-N-(4-(7-phenoxyheptylpiperazin-1-yl)butyl)guanidine [MeSH Supplementary Concept]
- N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidinylmethyl)phenyl)cyclobutanecarboxamide [MeSH Supplementary Concept]
- bavisant [MeSH Supplementary Concept]
Record concept(s)
- histamine H3 antagonists [MeSH concept]
See also (suggested by CISMeF)
- 6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing histamine H3 receptor antagonist (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 3-(1'-cyclobutylspiro(4H-1,3-benzodioxine-2,4'-piperidine)-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one [MeSH Supplementary Concept]
- N-(2-(4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)-1-piperazinyl)-1-methyl-2-oxoethyl)-2-furamide [MeSH Supplementary Concept]
- ciproxifan [MeSH Supplementary Concept]
- clobenpropit [MeSH Supplementary Concept]
- histamine H3R antagonist 2-18 [MeSH Supplementary Concept]
- iodophenpropit [MeSH Supplementary Concept]
- thioperamide [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing histamine H3 receptor antagonist (product) [SNOMED CT concept]
- Substance with histamine H3 receptor antagonist mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients